76 related articles for article (PubMed ID: 16337862)
1. Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer.
Vleugel MM; Greijer AE; van der Wall E; van Diest PJ
Cancer Genet Cytogenet; 2005 Dec; 163(2):168-72. PubMed ID: 16337862
[TBL] [Abstract][Full Text] [Related]
2. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
[TBL] [Abstract][Full Text] [Related]
3. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ
Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615
[TBL] [Abstract][Full Text] [Related]
4. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.
Fu XS; Choi E; Bubley GJ; Balk SP
Prostate; 2005 May; 63(3):215-21. PubMed ID: 15538748
[TBL] [Abstract][Full Text] [Related]
5. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer.
Apaydin I; Konac E; Onen HI; Akbaba M; Tekin E; Ekmekci A
Arch Med Res; 2008 Apr; 39(3):338-45. PubMed ID: 18279708
[TBL] [Abstract][Full Text] [Related]
12. Construction of recombinant adenovirus vector containing a modified gene that codes for human hypoxia-inducible factor-1alpha without oxygen-dependent degradation domain.
Wei L; Lu J; Feng L; Li S; Shan J; Li Y
Plasmid; 2010 Jan; 63(1):20-6. PubMed ID: 19766670
[TBL] [Abstract][Full Text] [Related]
13. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1.
Wilson JL; Burchell J; Grimshaw MJ
Cancer Res; 2006 Dec; 66(24):11802-7. PubMed ID: 17178876
[TBL] [Abstract][Full Text] [Related]
14. Insulin-dependent leptin expression in breast cancer cells.
Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
[TBL] [Abstract][Full Text] [Related]
15. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
16. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB
Clin Cancer Res; 2006 Aug; 12(15):4562-8. PubMed ID: 16899602
[TBL] [Abstract][Full Text] [Related]
18. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients.
Fransén K; Fenech M; Fredrikson M; Dabrosin C; Söderkvist P
Mol Carcinog; 2006 Nov; 45(11):833-40. PubMed ID: 16865676
[TBL] [Abstract][Full Text] [Related]
19. c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner.
Yu B; Miao ZH; Jiang Y; Li MH; Yang N; Li T; Ding J
Cancer Res; 2009 Oct; 69(19):7704-12. PubMed ID: 19738058
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]